These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 25670222

  • 1. Myo-inositol vs. D-chiro inositol in PCOS treatment.
    Formuso C, Stracquadanio M, Ciotta L.
    Minerva Ginecol; 2015 Aug; 67(4):321-5. PubMed ID: 25670222
    [Abstract] [Full Text] [Related]

  • 2. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G, Cappelli V, Di Sabatino A, Massaro MG, De Leo V.
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [Abstract] [Full Text] [Related]

  • 3. Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients.
    Stracquadanio M, Ciotta L, Palumbo MA.
    Gynecol Endocrinol; 2018 Jun; 34(6):495-501. PubMed ID: 29265900
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
    Zacchè MM, Caputo L, Filippis S, Zacchè G, Dindelli M, Ferrari A.
    Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
    [Abstract] [Full Text] [Related]

  • 5. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Pizzo A, Laganà AS, Barbaro L.
    Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
    [Abstract] [Full Text] [Related]

  • 6. The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study.
    La Marca A, Grisendi V, Dondi G, Sighinolfi G, Cianci A.
    Gynecol Endocrinol; 2015 Jan; 31(1):52-6. PubMed ID: 25268566
    [Abstract] [Full Text] [Related]

  • 7. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
    Unfer V, Porcaro G.
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H, Xing C, Zhang J, He B.
    Reprod Health; 2021 Aug 18; 18(1):171. PubMed ID: 34407851
    [Abstract] [Full Text] [Related]

  • 9. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
    Dinicola S, Chiu TT, Unfer V, Carlomagno G, Bizzarri M.
    J Clin Pharmacol; 2014 Oct 18; 54(10):1079-92. PubMed ID: 25042908
    [Abstract] [Full Text] [Related]

  • 10. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.
    Nordio M, Proietti E.
    Eur Rev Med Pharmacol Sci; 2012 May 18; 16(5):575-81. PubMed ID: 22774396
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study.
    Kachhawa G, Senthil Kumar KV, Kulshrestha V, Khadgawat R, Mahey R, Bhatla N.
    Int J Gynaecol Obstet; 2022 Aug 18; 158(2):278-284. PubMed ID: 34624138
    [Abstract] [Full Text] [Related]

  • 12. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
    Minozzi M, Nordio M, Pajalich R.
    Eur Rev Med Pharmacol Sci; 2013 Feb 18; 17(4):537-40. PubMed ID: 23467955
    [Abstract] [Full Text] [Related]

  • 13. Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome.
    Fruzzetti F, Capozzi A, Canu A, Lello S.
    Gynecol Endocrinol; 2019 Jun 18; 35(6):506-510. PubMed ID: 30612488
    [Abstract] [Full Text] [Related]

  • 14. Inositol as putative integrative treatment for PCOS.
    Genazzani AD.
    Reprod Biomed Online; 2016 Dec 18; 33(6):770-780. PubMed ID: 27717596
    [Abstract] [Full Text] [Related]

  • 15. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.
    Pustotina O, Myers SH, Unfer V, Rasulova I.
    Gynecol Obstet Invest; 2024 Dec 18; 89(2):131-139. PubMed ID: 38295772
    [Abstract] [Full Text] [Related]

  • 16. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
    Fruzzetti F, Perini D, Russo M, Bucci F, Gadducci A.
    Gynecol Endocrinol; 2017 Jan 18; 33(1):39-42. PubMed ID: 27808588
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.